ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: Evogene Ltd (EVGN) Report Updated: Nov 28, 2016 | Print This Page

Get more stock ratings by Louis Navellier

Evogene Ltd (EVGN)

Rating: Sell Volatility: Moderate
Total Grade: D Industry: Biotechnology
Competitors: ARIA,CLCD,PIP,MNOV

Stock Analysis

Rating: Monthly View

A
B
C
D
F
December January February March April May June July August September October November

Rating: Weekly View

This Week: D down upgrade
Last Week: N same downgrade
Two Weeks Ago: D up no change
service keys

Evogene Ltd© quotemedia

Company Profile

Evogene Ltd. operates as a plant genomics company that uses a technology infrastructure to enhance seed traits underlying crop productivity. The company operates in two segments, Evogene and Evofuel. The Evogene segment develops technologies to enhance plant performance through seed traits and ag-chemicals. Its seed trait operation utilizes to address yield and abiotic stress and biotic stress traits through the genetic modification or breeding of seeds; and ag-chemical operations utilize to develop novel crop protection and crop enhancement products, including herbicides. The Evofuel segment develops species of the castor bean plant for second generation feedstock for use in the alternative fuel industry, primarily biodiesel and biojet. Its products focus on various crops comprising corn, soybean, wheat, rice, and cotton. Evogene Ltd. has strategic collaborations with agricultural companies primarily to develop traits for yield and abiotic stress tolerance, such as enhanced tolerance to drought, heat, and salinity; and biotic stress resistance, including resistance to disease, pests, and insects. Evogene Ltd. has collaboration with BASF SE for the discovery and development of novel herbicides. The company was founded in 1999 and is headquartered in Rehovot, Israel.